Top Stories
- As Netanyahu vows Iran payback, markets watch for dangers of further escalation
- Eli Lilly to build $4.5 billion research and manufacturing center to propel drug pipeline
- Recursion gets FDA approval to begin phase 1 trials of AI-discovered cancer treatment
- Red-hot refinance demand retreats after tiny bump higher in mortgage rates
- Facebook owner Meta forms data-sharing pact with UK banks to counter scams